Cargando…

Efficacy and Safety of Intravenous Immunoglobulin Treatment in Selected Neurological Diseases—One Centre’s Experience Based on the Therapy of 141 Patients

Background: Intravenous immunoglobulins (IVIg) are the first-choice drugs for the treatment of certain neuroimmune diseases. The aim of this study was to evaluate the efficacy and safety of IVIg in patients with selected nervous system diseases. Methods: The study enrolled patients who received IVIg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lasek-Bal, Anetta, Wagner-Kusz, Anna, Rogoż, Barbara, Cisowska-Babraj, Małgorzata, Gajewska, Gabriela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531894/ https://www.ncbi.nlm.nih.gov/pubmed/37762922 http://dx.doi.org/10.3390/jcm12185983

Ejemplares similares

Patent foramen ovale and cryptogenic stroke – a statistical or cause-and-effect relationship? A neurological point of view
por: Lasek-Bal, Anetta, et al.
Publicado: (2013)

Safety and Efficacy of Fingolimod and Natalizumab in Multiple Sclerosis After the Failure of First-Line Therapy: Single Center Experience Based on the Treatment of Forty-Four Patients
por: Puz, Przemysław, et al.
Publicado: (2016)

Cardiovascular diseases in patients 65 years and younger with non-cardiogenic stroke
por: Lasek-Bal, Anetta, et al.
Publicado: (2016)

The link between weight shift asymmetry and gait disturbances in chronic hemiparetic stroke patients
por: Szopa, Andrzej, et al.
Publicado: (2017)

The comparison of oxidative stress effect in classic and tubeless percutaneous nephrolithotomy
por: Bryniarski, Piotr, et al.
Publicado: (2018)

Percutaneous closure of the left atrial appendage for secondary prevention of stroke in patients with atrial fibrillation and contraindications to chronic anticoagulant therapy
por: Lasek-Bal, Anetta, et al.
Publicado: (2015)

Stent implantation into intracranial part of internal carotid artery in a patient with recurrent stroke, atrial fibrillation and iatrogenic bleeding during anticoagulant therapy
por: Lasek-Bal, Anetta, et al.
Publicado: (2013)

Elevated factor VIII level and stroke in patients without traditional risk factors associated with cardiovascular diseases
por: Anetta, Lasek-Bal, et al.
Publicado: (2013)

The Influence of Selected Meteorological Factors on the Prevalence and Course of Stroke
por: Zaręba, Katarzyna, et al.
Publicado: (2021)

Plasma Levels of Occludin and Claudin-5 in Acute Stroke Are Correlated with the Type and Location of Stroke but Not with the Neurological State of Patients—Preliminary Data
por: Lasek-Bal, Anetta, et al.
Publicado: (2020)

Virus safety of intravenous immunoglobulin: Future challenges
por: Boschetti, Nicola, et al.
Publicado: (2005)

The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis
por: Lee, Soon‐Tae, et al.
Publicado: (2022)

Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies
por: Berzero, Giulia, et al.
Publicado: (2018)

Cerebral microembolism during atrial fibrillation ablation can result from the technical aspects and mostly does not cause permanent neurological deficit
por: Lasek-Bal, Anetta, et al.
Publicado: (2020)

Diagnosis and therapy of myasthenia gravis—the patients’ perspective: a cross-sectional study
por: Sobierajski, Tomasz, et al.
Publicado: (2023)

Efficacy and safety of intravenous immunoglobulins for the treatment of viral encephalitis: a systematic literature review
por: Wagner, Judith N., et al.
Publicado: (2021)

Inflammatory markers in patients with internal carotid artery stenosis
por: Puz, Przemysław, et al.
Publicado: (2013)

72 hour Holter monitoring, 7 day Holter monitoring, and 30 day intermittent patient-activated heart rhythm recording in detecting arrhythmias in cryptogenic stroke patients free from arrhythmia in a screening 24 h Holter
por: Kułach, Andrzej, et al.
Publicado: (2020)

Supraventricular Runs in 7-Day Holter Monitoring Are Related to Increased Incidence of Atrial Fibrillation in a 3-Year Follow-Up of Cryptogenic Stroke Patients Free from Arrhythmia in a 24 h-Holter
por: Kułach, Andrzej, et al.
Publicado: (2021)

INTRAVENOUS IMMUNOGLOBULIN IN DERMATOLOGY
por: Dhar, Sandipan
Publicado: (2009)

Evaluation of Influence of Chronic Kidney Disease and Sodium Disturbances on Clinical Course of Acute and Sub-Acute Stage First-Ever Ischemic Stroke
por: Lasek-Bal, Anetta, et al.
Publicado: (2014)

Intravenous Immunoglobulin Treatment in Chronic Neurological Diseases: Do We Have Maintenance Dose Right?
por: Dolezal, Ondrej
Publicado: (2014)

Intravenous Immunoglobulin-Associated Elevation of Liver Enzymes in Neurological Autoimmune Disorder: A Case Series
por: Behera, Anupama, et al.
Publicado: (2020)

Effect of intravenous immunoglobulin therapy on the prognosis of patients with severe fever with thrombocytopenia syndrome and neurological complications
por: Liu, Yun, et al.
Publicado: (2023)

The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?
por: Han, Ji Whan
Publicado: (2017)

Low Concentration of BDNF in the Acute Phase of Ischemic Stroke as a Factor in Poor Prognosis in Terms of Functional Status of Patients
por: Lasek-Bal, Anetta, et al.
Publicado: (2015)

Clinical and Non-Clinical Determinants of the Effect of Mechanical Thrombectomy and Post-Stroke Functional Status of Patients in Short and Long-Term Follow-Up
por: Lasek-Bal, Anetta, et al.
Publicado: (2021)

Use of intravenous immunoglobulin in the Department of Neurology at Ninewells Hospital, 2008–2009: Indications for utilization and cost-effectiveness
por: O’ Riordan, Jonathan, et al.
Publicado: (2010)

Complex interventional treatment in a patient with atrial fibrillation and stroke caused by large carotid artery thrombus: a case report
por: Lasek-Bal, Anetta, et al.
Publicado: (2015)

Prognostic Role of Chronic Rhinosinusitis in Acute Ischemic Stroke Patients Undergoing Mechanical Thrombectomy
por: Puz, Przemysław, et al.
Publicado: (2021)

Efficacy and safety of a new intravenous immunoglobulin (Panzyga(®)) in chronic immune thrombocytopenia
por: Arbach, O., et al.
Publicado: (2019)

Subarachnoid Haemorrhage—Incidence of Hospitalization, Management and Case Fatality Rate—In the Silesian Province, Poland, in the Years 2009–2019
por: Łabuz-Roszak, Beata, et al.
Publicado: (2022)

Intravenous Immunoglobulin in the Management of Lupus Nephritis
por: Wenderfer, Scott E., et al.
Publicado: (2012)

Pemphigoid gestationis and intravenous immunoglobulin therapy()
por: Yang, Anes, et al.
Publicado: (2018)

Intravenous Immunoglobulin for Overwhelming Postsplenectomy Infection
por: Nakamura, Kensuke, et al.
Publicado: (2021)

Intravenous Immunoglobulin: Revisited – My Experience
por: Vaishampayan, Sanjeev S., et al.
Publicado: (2021)

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
por: Talaei, M., et al.
Publicado: (2021)

Intravenous immunoglobulin for the treatment of Kawasaki disease
por: Broderick, Cathryn, et al.
Publicado: (2023)

Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies
por: Perez, Elena E., et al.
Publicado: (2021)

Efficacy and safety of intravenous immunoglobulin for treating refractory livedoid vasculopathy: a systematic review
por: Gao, Yimeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_80kmjf4julftqv8g3qmil3tdra